Pyxis Oncology, Inc. — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-1
Book Value Per Share
$1
Free Cash Flow Per Share
$-1
Cash Per Share
$0
Revenue Per Share
$0
OCF Per Share
$-1
Return on Equity
-91.4%
Return on Assets
-64.0%
Return on Invested Capital
-76.6%
Current Ratio
3.41
Quick Ratio
3.41
Asset Turnover
0.11
Days Payables Outstanding
1663.75
R&D / Revenue
531.8%
SBC / Revenue
85.2%
Capex / Revenue
0.1%
Working Capital
$51M
Net Current Asset Value
$34M
Invested Capital
$53M
OCF / Net Income
0.80
FCF / Net Income
0.80
Accruals Ratio (Sloan)
-17.6%
Net Debt
$-67M
Net Debt / EBITDA
0.84
Capex Coverage
-7055.78
Tangible Common Equity
$53M
TCE / Total Assets
58.4%
NOPAT
$-67M
Cash ROIC
-72.9%
WC / Revenue
367.8%
Capex / D&A
0.00
Reinvestment Rate
5.3%
Asset Growth vs Revenue Growth
-27.6%
Stock Price (FY-end)
$1
Market Cap
$71M
P/S Ratio
5.16
P/B Ratio
1.34
P/TB Ratio
1.34
Enterprise Value
$5M
EV / Sales
0.33
FCF Yield
-88.9%
Shareholder Yield
-16.5%
R&D Yield
103.1%
Capex Yield
0.0%
Shares Variation (YoY)
6.3%
Beta (5Y)
1.06
Cost of Equity
9.8%
52W High
$5
52W Low
$1
Trailing Return 1Y
-27.7%
F-Score (Piotroski)
2.00
Z-Score (Altman)
-7.88
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.